CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 2. Effects of bryostatin-1 and GM-CSF on cell surface antigen expression by AML cell lines. U937 (A) and HL60 (B) cells were incubated for 120 h in the absence (Control) or presence of bryostatin-1 (Bryo, 10-8 M) with or without GM-CSF (200 units/ml) and then assessed for the surface expression of CD11b and CD14 by flow cytometry. Results represent means of five separate experiments; bars, SE. Ps were determined by ANOVA for the comparison of all treatment groups for both CD11b and CD14 expression.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation